Yunnan Botanee Bio-Technology Group Co Ltd (300957) — Cash Flow Reinvestment Rate
Yunnan Botanee Bio-Technology Group Co Ltd (300957) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥29.13 Million (capex CN¥29.13 Million ) from operating cash flow of CN¥125.55 Million. Explore 300957 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yunnan Botanee Bio-Technology Group Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Yunnan Botanee Bio-Technology Group Co Ltd across 9 annual periods. Also explore Yunnan Botanee Bio-Technology Group Co L balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Yunnan Botanee Bio-Technology Group Co Ltd. For live market cap and broader valuation context, see 300957 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | CN¥827.54 Million | CN¥976.60 Million | CN¥482.99 Million | ▼ -45.9% |
| 2024 | 1.56x | CN¥1.09 Billion | CN¥694.87 Million | CN¥378.38 Million | ▲ +20.6% |
| 2023 | 1.30x | CN¥792.33 Million | CN¥610.44 Million | CN¥274.28 Million | ▲ +168.5% |
| 2022 | 0.48x | CN¥371.91 Million | CN¥769.45 Million | CN¥353.42 Million | ▼ -80.3% |
| 2021 | 2.45x | CN¥2.83 Billion | CN¥1.15 Billion | CN¥270.68 Million | ▲ +501.8% |
| 2020 | 0.41x | CN¥175.77 Million | CN¥431.03 Million | CN¥89.45 Million | ▲ +72.3% |
| 2019 | 0.24x | CN¥121.87 Million | CN¥514.92 Million | CN¥61.01 Million | ▼ -23.4% |
| 2018 | 0.31x | CN¥31.56 Million | CN¥102.20 Million | CN¥31.56 Million | ▲ +359.1% |
| 2017 | 0.07x | CN¥13.62 Million | CN¥202.44 Million | CN¥13.62 Million | — |